Skye Peptides
Finnrick has tested 75 samples from Skye Peptides across 10 products.
Take Action
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Mazdutide | 5 | 6 May 2025 | 16 Aug 2025 | |||||
| Semaglutide | 9 | 17 Dec 2024 | 20 Mar 2025 | |||||
| Tirzepatide | 12 | 17 Dec 2024 | 11 May 2026 | |||||
| Ipamorelin | 5 | 27 Feb 2025 | 4 Feb 2026 | |||||
| Melanotan II | 4 | 27 Feb 2025 | 20 Mar 2025 | |||||
| Retatrutide | 12 | 17 Dec 2024 | 23 Apr 2026 | |||||
| Survodutide | 4 | 6 May 2025 | 21 May 2025 | |||||
| Tesamorelin | 5 | 14 May 2025 | 4 Feb 2026 | |||||
| CJC-1295 | 7 | 17 Dec 2024 | 20 May 2025 | |||||
| BPC-157 | 12 | 17 Dec 2024 | 22 Feb 2026 | |||||
The Skye Peptides samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Customer Reviews
These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.
Based on 9 overall satisfaction reports
People who submitted test requests to Finnrick gave Skye Peptides an average satisfaction rating of 5.0 out of 5 across 9 reports associated with samples received and tested by Finnrick.
Most recent Skye Peptides tests
Samples are tested in commercial labs
tests
products
Scores
First
Last
| Quantity | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Batch | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 11 May 2026 | Tirzepatide | View | 10mg | (no batch claim) | 10.4mg | +4.0% | 99.90% | low | TZ26-10-001 | White Label / Blue Crimp / Clear Cap | Lab E | Public | |
| 23 Apr 2026 | Retatrutide | View | 12mg | 13.0mg | 12.5mg | -3.6% | 99.20% | below LOQ | RET26-12-001 | White Label / Silver Crimp / Clear Green Cap | Lab E | Public | |
| 9 Apr 2026 | Retatrutide | View | 25mg | (no batch claim) | 24.6mg | -1.6% | 99.90% | n/a | RET26-24-001 | White Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 22 Feb 2026 | BPC-157 | View | 5mg | 6.0mg | 5.33mg | -11.0% | 99.88% | low | BPC25-05-002 | Red Label / Silver Crimp / Red Cap | Lab E | Public | |
| 18 Feb 2026 | Tirzepatide | View | 30mg | (no batch claim) | 30.7mg | +2.3% | 99.90% | n/a | (no batch ID) | No Label / Silver Crimp / Black Cap | Lab E | Public | |
| 4 Feb 2026 | Ipamorelin | View | 10mg | 11.6mg | 10.4mg | -10.2% | 99.80% | n/a | IPA-10-001 | Blue Label / Silver Crimp / Blue Cap | Lab G | Public | |
| 4 Feb 2026 | Tesamorelin | View | 10mg | (no batch claim) | 11.6mg | +16.0% | 99.70% | n/a | (no batch ID) | Purple Label / Black Crimp / Clear Purple Cap | Lab G | Public | |
Corrections
- 6 Feb 2026: Tirzepatide
- Two samples of Tirzepatide (4t7h769 and 9872swd) were erroneously attributed to Skye Peptides and removed from the database pending an investigation.
- 14 May 2025: BPC-157
- Lab C test 5 May 2025: updated quantity rating, clerical error, value was missing.
About Skye Peptides Test Results From Finnrick
Skye Peptides is a peptide vendor with multiple products tracked in the independent testing dataset collected by Finnrick. This page compiles recent, batch-level test results across 10 products and 75 tests, including scores, test dates, batch IDs, and lab details. This enables you to compare quality over time, not just marketing claims.
Each tested sample receives a 0–10 score, with 10 being the best possible value. It is the total of three components: purity (0–4 points), quantity accuracy vs. the label or batch claim (0–4 points), and batch information quality (0–2 points).
When several test results are available for a product and vendor pair, you’ll also find a Finnrick Rating (A–E, where A is best and E is worst, X if an insufficient number of tests is available, or F in rare cases of documented and widespread fraud) and customer satisfaction reports with sub-scores that provide additional context. Use the table above to review purity, quantity accuracy, consistency between batches, and any notable outliers surfaced in Finnrick testing data.
Skye Peptides Testing Activity & Score Summary
In the past 30 days, Finnrick has published no new test results for Skye Peptides, and 3 in the past three months. The overall dataset includes 75 tested samples with an average score of 7.2/10 across all products.
Across 75 identity-tested samples, 100% were confirmed to contain the expected peptide (identity pass rate). Among those that passed, median purity was 99.6%. Approximately 93% of passing samples tested at or above 98% purity.
Here is a closer look at the most frequently tested products (top 3):
- Tirzepatide (12 tests, 100% identity pass, median purity 99.8%) — Test scores are highly variable, ranging from 6.2 to 10.0 (average 8.0/10), suggesting significant batch-to-batch differences.
- Tesamorelin (5 tests, 100% identity pass, median purity 99.4%) — Test scores are reasonably consistent, averaging 6.1/10 with a moderate spread from 5.0 to 7.1.
- Retatrutide (12 tests, 100% identity pass, median purity 99.8%) — Test scores are highly variable, ranging from 6.0 to 10.0 (average 8.1/10), suggesting significant batch-to-batch differences.